Benitec Biopharma Ltd ADR (BNTC) — Cash Flow Reinvestment Rate

Latest as of September 2018: 0.00x

Benitec Biopharma Ltd ADR (BNTC) has a Cash Flow Reinvestment Rate of 0.00x as of September 2018, reinvesting $26.00K (capex $26.00K ) from operating cash flow of $5.87 Million. See Benitec Biopharma Ltd ADR free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

$26.00K

Capex + Investments

Operating Cash Flow

$5.87 Million

USD

Capital Expenditures

$26.00K

USD

Benitec Biopharma Ltd ADR Cash Flow Reinvestment Rate (2019–2019)

Historical reinvestment intensity for Benitec Biopharma Ltd ADR across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Benitec Biopharma Ltd ADR.

Annual Cash Flow Reinvestment Rate for Benitec Biopharma Ltd ADR (2019–2019)

Year-by-year capital reinvestment analysis for Benitec Biopharma Ltd ADR. See financial agility of Benitec Biopharma Ltd ADR to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2019	0.20x	$973.40K	$4.79 Million	$403.40K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow